LRRK2 and inflammatory bowel disease: Further, taking these data together with the findings that patients with Crohn’s disease (inflammatory bowel disease, IBD) have a higher risk of developing PD (meta-analysis55) may also point to a role for LRRK2 in the GI in the development of PD.